Osteonecrosis of the Jaw Associated With Bevacizumab in Treatment: A Case Series Using the FDA Adverse Event Reporting System (FAERS) Database

被引：0
|
作者：
Ahdi, Hardeep S. [1 ]
Wichelmann, Thomas A. [2 ]
Pandravada, Sasirekha [2 ]
Ehrenpreis, Eli [3 ]
机构：
[1] Advocate Lutheran Gen Hosp, Chicago, IL USA
[2] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
[3] Advocate Lutheran Gen, Evanston, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S166
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [1] Time to onset analysis of letrozole associated osteonecrosis of jaw in FDA adverse event reporting system (FAERS) database
    Viswam, Subeesh Kulangara
    Reddy, Neha
    Gouri, Nair
    Sai, Minnikanti Satya
    Kunnavil, Radhika
    Maheswari, Eswaran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 460 - 460
  • [2] BEVACIZUMAB-ASSOCIATED ESOPHAGEAL PERFORATIONS: A CASE SERIES FROM THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE
    Wichelmann, Thomas Adam
    Weaver, Mandy
    AbdulMujeeb, Sufyan
    Ehnrenpreis, Eli D.
    GASTROENTEROLOGY, 2021, 160 (06) : S16 - S16
  • [3] Osteonecrosis of the Jaw Associated With Anti-Tumor Necrosis Factor Biologic Medications: A Case Series Using the FDA Adverse Event Reporting System Database
    Wichelmann, Thomas A.
    Ahdi, Hardeep
    Pandravada, Sasirekha
    Ehrenpreis, Eli D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S375 - S375
  • [4] Bevacizumab and gastrointestinal perforations: a review from the FDA Adverse Event Reporting System (FAERS) database
    Wichelmann, Thomas A.
    Abdulmujeeb, Sufyan
    Ehrenpreis, Eli D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (10) : 1290 - 1297
  • [5] Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
    Morris, Robert
    Ali, Rahinatu
    Cheng, Feng
    CURRENT DRUG TARGETS, 2024, 25 (07) : 454 - 464
  • [6] Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
    He, Chang-Zhu
    Qiu, Qin
    Lu, Song-Jie
    Xue, Fu-Li
    Liu, Jun-Qiao
    He, Yu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [7] Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA Adverse Event Reporting System (FAERS) database
    Andrews, Michael B.
    Adler, Douglas G.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (07) : 389 - 395
  • [8] Development of a Medication-Related Osteonecrosis of the Jaw Prediction Model Using the FDA Adverse Event Reporting System Database and Machine Learning
    Toriumi, Shinya
    Shimokawa, Komei
    Yamamoto, Munehiro
    Uesawa, Yoshihiro
    PHARMACEUTICALS, 2025, 18 (03)
  • [9] Evaluation of Spontaneous Adverse Event Reports for Osteonecrosis of the Jaw (ONJ) Attributed to Denosumab and Zoledronic Acid Within the FDA Adverse Events Reporting System (FAERS)
    Mekkawy, Mohamed A.
    El-Fass, Kareem
    Mohammad, Reem Nagib
    Abou-Ali, Adel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 395 - 396
  • [10] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    HELIYON, 2024, 10 (14)
12345